Markets · UK
London Exchange
3,818 stocks listed, 3,603 traded in the last 30 days and shown below. Prices in pence (GBX) for UK-listed shares and in the stock's own currency for the London international order book (marked next to each close). Price, return and technical signals for now; the fundamental X-Ray follows when fundamentals data for this market is added. Data as of 23 Oct 2026.
| Company | Close | Today | 3 months | 1 year | RSI | vs 52w high |
|---|---|---|---|---|---|---|
| 0KCC Insight Molecular Diagnostics | 2.790 USD | −0.4% | −39.7% | −56.0% | 34 | −64.1% |
| 0A4D Equillium, Inc. | 1.200 USD | −4.0% | −57.4% | – | 33 | −66.0% |
| 0A7K Abundia Global Impact Group Inc. | 0.990 USD | +2.1% | −10.8% | −83.3% | 48 | −85.9% |
| CHLL Chill Brands Group PLC | 1.700 GBX | +0.0% | −22.7% | −85.8% | 0 | −86.9% |
| 0.830 EUR | −2.4% | −13.1% | −72.8% | 43 | −72.8% | |
| 0.789 EUR | +1.7% | −35.9% | −75.1% | 52 | −76.6% | |
| TRLS Trellus Health plc | 0.120 GBX | +0.0% | +0.0% | −85.5% | 54 | −94.9% |
| 0.131 USD | +3.4% | −44.3% | – | 31 | −88.3% | |
| 0RAG ABIONYX Pharma S.A. | 1.470 EUR | +1.5% | −21.0% | −58.8% | 30 | −72.2% |
| 0A6I Soligenix, Inc. | 0.360 USD | +0.7% | −1.6% | −76.7% | 49 | −78.1% |
| 0.002 GBX | +0.0% | +0.0% | −80.0% | 37 | −85.7% | |
| GNIP GenIP PLC | 2.650 GBX | +0.0% | −35.4% | −88.2% | 22 | −90.2% |
| 0.572 USD | +1.6% | −46.1% | – | 34 | −90.6% | |
| 2.120 USD | +2.9% | −44.2% | – | 44 | −70.8% | |
| 0J4V Heron Therapeutics Inc. | 0.372 USD | −0.9% | −11.4% | −72.5% | 55 | −76.3% |
| 0ELV Guerbet | 5.820 EUR | −0.9% | −35.8% | −60.8% | 11 | −67.9% |
| 0A8D Q/C Technologies, Inc. | 0.502 USD | +0.3% | −84.7% | −87.8% | 31 | −94.6% |
| 0RAE Amoeba S.A. | 0.295 EUR | −1.2% | −56.4% | −73.0% | 21 | −74.3% |
| 0ABN Norse Atlantic ASA | 0.255 NOK | −5.7% | −34.7% | −94.0% | 35 | −94.3% |
| 1.309 USD | −4.5% | −47.2% | −84.9% | 29 | −86.1% | |
| 4.240 USD | +1.0% | −41.3% | −71.5% | 48 | −78.9% | |
| 0KDU Bed Bath & Beyond | 1.570 USD | +6.8% | −68.1% | −81.5% | 28 | −83.2% |
| 2.400 EUR | +2.4% | −35.4% | −72.0% | 42 | −75.3% | |
| GSC GS Chain PLC | 0.150 GBX | +0.0% | −40.0% | −53.8% | 69 | −78.6% |
| 13.47 EUR | +0.0% | −10.4% | −84.3% | 49 | −84.9% | |
| 0.230 EUR | −8.7% | −35.0% | −60.3% | 40 | −69.3% | |
| SPDI Secure Property Development & Inve... | 0.400 GBX | +0.0% | −27.3% | −77.1% | 1 | −80.0% |
| 0AB4 Lilium N.V. | 0.000 USD | +0.0% | +0.0% | −99.5% | 46 | −99.0% |
| 1.180 USD | +2.7% | −72.5% | −93.3% | 36 | −93.7% | |
| AST Ascent Resources plc | 0.004 GBX | +0.0% | +0.0% | −99.1% | 14 | −99.4% |
| 0AC1 Hexagon Purus ASA | 4.150 NOK | −2.4% | −54.9% | −75.6% | 32 | −80.2% |
| 3.210 EUR | +0.0% | −45.6% | −70.7% | 23 | −74.2% | |
| 0GYZ Nordic Mining ASA | 0.554 NOK | +11.7% | −87.8% | −96.2% | 30 | −97.0% |
| 0HS8 Lisata Therapeutics | 1.000 USD | −5.7% | −72.3% | −58.4% | 36 | −80.4% |
| 0.147 USD | −9.0% | −72.8% | −89.8% | 22 | −90.2% | |
| 0JEV Option NV | 3.630 EUR | – | −30.2% | −55.7% | 41 | −76.4% |
| 0A4Y AIM ImmunoTech Inc. | 0.159 USD | −7.8% | −34.4% | −93.8% | 37 | −94.4% |
| 0ABZ Hydrogen Refueling Solutions | 0.709 | −7.2% | −47.1% | −75.5% | 35 | −77.1% |
| 0WA2 Cellectis S.A. | 0.936 EUR | −1.8% | −62.4% | −68.3% | 27 | −80.3% |
| 0.672 SEK | −3.4% | −58.9% | −79.8% | 18 | −80.2% | |
| 5.203 SEK | +1.5% | −66.2% | −82.7% | 16 | −85.3% | |
| 2.270 USD | −12.0% | −28.4% | −76.4% | 36 | −77.2% | |
| AMIF Amicorp FS (UK) PLC | 0.250 USD | −16.7% | −75.6% | −84.9% | 5 | −85.0% |
| 0K2H Moleculin Biotech, Inc. | 0.266 USD | −9.3% | −87.6% | −97.9% | 22 | −98.5% |
| 0JQ2 KALA BIO, Inc. | 0.185 USD | +0.1% | −71.3% | −99.6% | 20 | −99.8% |
| 0QGG DIC Asset AG | 0.403 EUR | −5.4% | −59.9% | −79.4% | 44 | −84.5% |
| 1.780 USD | −1.9% | −55.4% | −91.3% | 23 | −91.8% | |
| 0A8I Genprex, Inc. | 1.810 USD | −11.3% | −76.2% | −99.1% | 23 | −99.5% |
| 0.584 EUR | – | −64.9% | −77.4% | 34 | −78.7% | |
| 0A50 Co-Diagnostics, Inc. | 0.559 USD | −4.6% | −74.3% | −94.2% | 25 | −98.8% |
Prices are end-of-day closes in pence (GBX) for UK-listed shares and in the stock's own currency for the London international order book (marked next to each close). Educational only, not financial advice.